Skip to content
Journal

Understanding evidence

Purity, peptide content and biological activity are three different measurements

By Proof Line Peptides · Published · 3 min read

Purity asks what proportion of the detected peptide-related material is the target. Content asks how much of the sample's mass is peptide at all. Biological activity asks whether the molecule does something measurable in a defined system. Three questions, three methods, three results that can point in different directions.

Most confusion about peptide documentation comes from collapsing these into one word, “quality”, and then reading a single percentage as a verdict on all three.

The three questions side by side

PurityTypically a relative peak-area measurement by reversed-phase HPLC or UHPLC, expressed against the peptide-related impurities the method detects under its own conditions.
Peptide contentWhat fraction of the weighed sample is peptide. Water, residual salts and counter-ions contribute mass without being the target peptide.
Biological activityWhether the material produces a defined effect in a specified assay or system. Requires a biological method; it is not derivable from a chromatogram.
IdentityWhether the material is the named molecule at all, usually approached by mass spectrometry. Purity presupposes identity rather than proving it.

The purity figure is defined relative to what the method detects, which is why the method conditions matter as much as the number. Anything the method does not resolve or does not detect is outside the percentage. [GenScript peptide purity guidance]

Three illustrative cases

The following figures are invented for teaching and describe no real product, lot or test. They exist to show how the three measurements can disagree.

Illustrative case A: high purity, low content

A hypothetical report states 99% purity by HPLC. A separate hypothetical content determination on the same material returns 78% peptide content, the remainder being water, salts and counter-ions. Both figures can be true at once: almost all the detected peptide material is the target, and a meaningful part of the vial's mass is not peptide. Anyone calculating a concentration from the label mass alone would be working from the wrong number. [MilliporeSigma peptide amount explanation]

Illustrative case B: identity unstated

A hypothetical report shows a single clean chromatographic peak and a purity figure, but contains no mass spectrometry and no sequence confirmation. A clean peak establishes that one species dominates what the method detected. It does not establish which species. High purity of an unidentified compound is not reassurance.

Illustrative case C: purity without activity

A hypothetical material is confirmed as the correct sequence at high purity, but was handled in a way that affected its conformation. Sequence and purity results can remain unchanged while an activity assay reads differently, because the assay is asking a question the chromatogram never asked.

“99% pure” does not mean safe

This is the single most common misreading. A purity result is a compositional, method-relative measurement. It is not a sterility test, not an endotoxin test, not a stability statement, and not an assessment of safety or effectiveness in people. Pharmacopeial and technical resources treat these as separate attributes precisely because they cannot substitute for one another. [USP peptide quality resources][GenScript peptide quality overview]

Frequently asked

If purity is 99%, is 1% an impurity I should worry about?
The figure describes the relative proportion of peptide-related material the method detected, so the remaining percentage is defined by that method, not by a general safety scale. It is not a toxicology result and cannot be read as one.
Which measurement matters most?
It depends entirely on the question being asked. Identity matters first, because purity and content only make sense once you know what the molecule is. After that, content matters for any mass arithmetic, and activity matters only if an activity claim is being made.
Can a supplier report content instead of purity?
They are different determinations and one does not replace the other. A report that gives only one of them has answered only one question; note the other as not reported rather than assuming a value.
Does an activity result mean a compound works in people?
No. An activity result belongs to the assay system it was run in. Moving from an assay to cells, to animals, to people is a series of separate evidence steps, each of which can fail.

References

  1. GenScript technical resource describing peptide purity reporting. View source
  2. MilliporeSigma technical article explaining how reported peptide amount relates to net peptide content. View source
  3. United States Pharmacopeia resource on synthetic peptide quality attributes. View source
  4. GenScript technical overview of peptide quality attributes. View source